[1]
Khan, L. et al. 2020. Evaluation of Myelosupression during Imatinib Mesylate Therapy in Patients with Chronic Myeloid Leukaemia. Journal of Armed Forces Medical College, Bangladesh. 15, 2 (Dec. 2020), 189–192. DOI:https://doi.org/10.3329/jafmc.v15i2.50833.